Back to mobile site

Exact Sciences (EXAS) Misses Q3 EPS by 1c

October 29, 2015 8:25 AM EDT

Exact Sciences (NASDAQ: EXAS) reported Q3 EPS of ($0.45), $0.01 worse than the analyst estimate of ($0.44). Revenue for the quarter came in at $12.6 million versus the consensus estimate of $12.56 million.

For earnings history and earnings-related data on Exact Sciences (EXAS) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings